Structure

Physi-Chem Properties

Molecular Weight:  300.06
Volume:  291.273
LogP:  2.618
LogD:  2.263
LogS:  -3.831
# Rotatable Bonds:  3
TPSA:  96.97
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.554
Synthetic Accessibility Score:  2.426
Fsp3:  0.125
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.93
MDCK Permeability:  1.2375551705190446e-05
Pgp-inhibitor:  0.006
Pgp-substrate:  0.234
Human Intestinal Absorption (HIA):  0.034
20% Bioavailability (F20%):  0.009
30% Bioavailability (F30%):  0.965

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.108
Plasma Protein Binding (PPB):  86.65093231201172%
Volume Distribution (VD):  0.944
Pgp-substrate:  14.958888053894043%

ADMET: Metabolism

CYP1A2-inhibitor:  0.97
CYP1A2-substrate:  0.811
CYP2C19-inhibitor:  0.489
CYP2C19-substrate:  0.069
CYP2C9-inhibitor:  0.757
CYP2C9-substrate:  0.858
CYP2D6-inhibitor:  0.737
CYP2D6-substrate:  0.321
CYP3A4-inhibitor:  0.499
CYP3A4-substrate:  0.141

ADMET: Excretion

Clearance (CL):  2.968
Half-life (T1/2):  0.846

ADMET: Toxicity

hERG Blockers:  0.016
Human Hepatotoxicity (H-HT):  0.059
Drug-inuced Liver Injury (DILI):  0.879
AMES Toxicity:  0.413
Rat Oral Acute Toxicity:  0.009
Maximum Recommended Daily Dose:  0.063
Skin Sensitization:  0.524
Carcinogencity:  0.028
Eye Corrosion:  0.006
Eye Irritation:  0.917
Respiratory Toxicity:  0.08

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC39819

Natural Product ID:  NPC39819
Common Name*:   Sydowinin A
IUPAC Name:   methyl 8-hydroxy-6-(hydroxymethyl)-9-oxoxanthene-1-carboxylate
Synonyms:   Sydowinin A
Standard InCHIKey:  UBYOEDLUKKPPPN-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C16H12O6/c1-21-16(20)9-3-2-4-11-13(9)15(19)14-10(18)5-8(7-17)6-12(14)22-11/h2-6,17-18H,7H2,1H3
SMILES:  COC(=O)c1cccc2c1c(=O)c1c(o2)cc(cc1O)CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1812028
PubChem CID:   23872092
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31451 Aspergillus sydowii Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[18505285]
NPO31451 Aspergillus sydowii Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21718031]
NPO31451 Aspergillus sydowii Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[23647825]
NPO31451 Aspergillus sydowii Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[24057165]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 28.73 % PMID[529721]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10.0 ug.mL-1 PMID[529721]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 38.1 % PMID[529721]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC39819 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9795 High Similarity NPC281272
0.9589 High Similarity NPC70764
0.9452 High Similarity NPC71055
0.9392 High Similarity NPC470107
0.9262 High Similarity NPC295036
0.9257 High Similarity NPC228012
0.9205 High Similarity NPC135522
0.9184 High Similarity NPC469764
0.9133 High Similarity NPC202595
0.9128 High Similarity NPC2569
0.9128 High Similarity NPC172329
0.9122 High Similarity NPC469758
0.9041 High Similarity NPC145673
0.902 High Similarity NPC237560
0.9013 High Similarity NPC154683
0.9013 High Similarity NPC474843
0.9013 High Similarity NPC40356
0.9013 High Similarity NPC473967
0.9013 High Similarity NPC273483
0.9007 High Similarity NPC290954
0.9007 High Similarity NPC147735
0.9007 High Similarity NPC255641
0.9 High Similarity NPC5537
0.8968 High Similarity NPC186113
0.8926 High Similarity NPC184649
0.8926 High Similarity NPC303185
0.8919 High Similarity NPC310340
0.8904 High Similarity NPC18457
0.8903 High Similarity NPC44199
0.8903 High Similarity NPC263483
0.8889 High Similarity NPC217447
0.8867 High Similarity NPC267509
0.8867 High Similarity NPC196114
0.8867 High Similarity NPC300540
0.8867 High Similarity NPC299011
0.8859 High Similarity NPC113770
0.8839 High Similarity NPC146211
0.8831 High Similarity NPC477691
0.8824 High Similarity NPC232645
0.8824 High Similarity NPC470569
0.8824 High Similarity NPC72958
0.8816 High Similarity NPC291049
0.8816 High Similarity NPC233267
0.8812 High Similarity NPC234331
0.8808 High Similarity NPC118027
0.8808 High Similarity NPC126767
0.8808 High Similarity NPC190648
0.8808 High Similarity NPC56433
0.8808 High Similarity NPC245584
0.8808 High Similarity NPC312929
0.8808 High Similarity NPC289042
0.8805 High Similarity NPC178281
0.88 High Similarity NPC311144
0.88 High Similarity NPC32470
0.88 High Similarity NPC131766
0.88 High Similarity NPC134621
0.8797 High Similarity NPC473961
0.8792 High Similarity NPC202981
0.8792 High Similarity NPC1534
0.8792 High Similarity NPC73028
0.8784 High Similarity NPC275734
0.8776 High Similarity NPC1268
0.8776 High Similarity NPC268691
0.8773 High Similarity NPC68381
0.8766 High Similarity NPC253904
0.8766 High Similarity NPC271681
0.8766 High Similarity NPC87708
0.8766 High Similarity NPC321363
0.8766 High Similarity NPC175978
0.8766 High Similarity NPC477690
0.8758 High Similarity NPC470568
0.8758 High Similarity NPC227122
0.8758 High Similarity NPC474660
0.8758 High Similarity NPC325983
0.8758 High Similarity NPC475717
0.8758 High Similarity NPC294646
0.8758 High Similarity NPC119929
0.875 High Similarity NPC7025
0.875 High Similarity NPC105415
0.875 High Similarity NPC29160
0.875 High Similarity NPC27221
0.875 High Similarity NPC39195
0.875 High Similarity NPC153417
0.875 High Similarity NPC256672
0.8742 High Similarity NPC99454
0.8742 High Similarity NPC163846
0.8742 High Similarity NPC237208
0.8742 High Similarity NPC130176
0.8742 High Similarity NPC225173
0.8742 High Similarity NPC211565
0.8733 High Similarity NPC19896
0.8733 High Similarity NPC95123
0.8733 High Similarity NPC274085
0.8733 High Similarity NPC66404
0.8733 High Similarity NPC89664
0.8726 High Similarity NPC324736
0.8725 High Similarity NPC250755
0.8725 High Similarity NPC49108
0.8725 High Similarity NPC105648
0.8718 High Similarity NPC154341
0.871 High Similarity NPC214632
0.871 High Similarity NPC208806
0.871 High Similarity NPC472799
0.871 High Similarity NPC210942
0.871 High Similarity NPC169990
0.8704 High Similarity NPC241874
0.8701 High Similarity NPC133856
0.8701 High Similarity NPC70016
0.8701 High Similarity NPC207346
0.8701 High Similarity NPC215921
0.8701 High Similarity NPC258249
0.8701 High Similarity NPC474417
0.8701 High Similarity NPC149526
0.8701 High Similarity NPC478148
0.8701 High Similarity NPC46564
0.8701 High Similarity NPC115324
0.8699 High Similarity NPC141934
0.8696 High Similarity NPC76647
0.8693 High Similarity NPC65589
0.8693 High Similarity NPC100985
0.8693 High Similarity NPC266499
0.8693 High Similarity NPC77325
0.8693 High Similarity NPC97029
0.8693 High Similarity NPC10027
0.8693 High Similarity NPC474052
0.8693 High Similarity NPC288036
0.8693 High Similarity NPC97028
0.8693 High Similarity NPC65775
0.8693 High Similarity NPC158338
0.8693 High Similarity NPC73236
0.8693 High Similarity NPC4423
0.8684 High Similarity NPC22005
0.8684 High Similarity NPC7943
0.8684 High Similarity NPC146884
0.8684 High Similarity NPC46941
0.8684 High Similarity NPC472036
0.8684 High Similarity NPC308200
0.8684 High Similarity NPC123202
0.8684 High Similarity NPC125801
0.8679 High Similarity NPC278329
0.8679 High Similarity NPC146837
0.8675 High Similarity NPC475161
0.8675 High Similarity NPC477860
0.8675 High Similarity NPC29577
0.8671 High Similarity NPC143050
0.8671 High Similarity NPC130955
0.8667 High Similarity NPC51106
0.8667 High Similarity NPC469542
0.8667 High Similarity NPC159855
0.8667 High Similarity NPC476473
0.8667 High Similarity NPC169479
0.8667 High Similarity NPC472006
0.8662 High Similarity NPC164110
0.8662 High Similarity NPC246647
0.8662 High Similarity NPC158542
0.8662 High Similarity NPC201127
0.8662 High Similarity NPC212967
0.8662 High Similarity NPC477833
0.8662 High Similarity NPC96342
0.8658 High Similarity NPC124365
0.8658 High Similarity NPC182421
0.8658 High Similarity NPC220106
0.8654 High Similarity NPC326910
0.8654 High Similarity NPC255807
0.8654 High Similarity NPC89625
0.8654 High Similarity NPC31018
0.8654 High Similarity NPC175192
0.8654 High Similarity NPC67396
0.8654 High Similarity NPC149618
0.865 High Similarity NPC30432
0.865 High Similarity NPC76128
0.865 High Similarity NPC111536
0.865 High Similarity NPC5029
0.865 High Similarity NPC271385
0.8649 High Similarity NPC280284
0.8649 High Similarity NPC99333
0.8649 High Similarity NPC188947
0.8645 High Similarity NPC207624
0.8645 High Similarity NPC75069
0.8642 High Similarity NPC165979
0.8642 High Similarity NPC99613
0.8642 High Similarity NPC222455
0.8642 High Similarity NPC49487
0.8642 High Similarity NPC163130
0.8636 High Similarity NPC60413
0.8636 High Similarity NPC158866
0.8636 High Similarity NPC213382
0.8636 High Similarity NPC164527
0.8636 High Similarity NPC150928
0.8636 High Similarity NPC267117
0.8636 High Similarity NPC473466
0.8634 High Similarity NPC477835
0.8634 High Similarity NPC125465
0.8634 High Similarity NPC178173
0.863 High Similarity NPC161632
0.8627 High Similarity NPC35150
0.8627 High Similarity NPC186397
0.8627 High Similarity NPC471642
0.8627 High Similarity NPC471641
0.8627 High Similarity NPC240622

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC39819 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8836 High Similarity NPD2346 Discontinued
0.8831 High Similarity NPD7819 Suspended
0.8816 High Similarity NPD3226 Approved
0.8767 High Similarity NPD1551 Phase 2
0.8658 High Similarity NPD3750 Approved
0.8533 High Similarity NPD1878 Clinical (unspecified phase)
0.8523 High Similarity NPD1549 Phase 2
0.8456 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8456 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8447 Intermediate Similarity NPD6232 Discontinued
0.8431 Intermediate Similarity NPD2532 Approved
0.8431 Intermediate Similarity NPD2533 Approved
0.8431 Intermediate Similarity NPD2534 Approved
0.8428 Intermediate Similarity NPD3749 Approved
0.8418 Intermediate Similarity NPD5402 Approved
0.8408 Intermediate Similarity NPD1934 Approved
0.8405 Intermediate Similarity NPD7473 Discontinued
0.84 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8385 Intermediate Similarity NPD6959 Discontinued
0.8354 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD7411 Suspended
0.8322 Intermediate Similarity NPD3748 Approved
0.8322 Intermediate Similarity NPD1510 Phase 2
0.8313 Intermediate Similarity NPD7075 Discontinued
0.8312 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8311 Intermediate Similarity NPD1607 Approved
0.8303 Intermediate Similarity NPD5844 Phase 1
0.8289 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.828 Intermediate Similarity NPD6599 Discontinued
0.8263 Intermediate Similarity NPD6559 Discontinued
0.825 Intermediate Similarity NPD7768 Phase 2
0.8239 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.8205 Intermediate Similarity NPD5403 Approved
0.8199 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8194 Intermediate Similarity NPD5401 Approved
0.8176 Intermediate Similarity NPD1240 Approved
0.8166 Intermediate Similarity NPD8313 Approved
0.8166 Intermediate Similarity NPD8312 Approved
0.8165 Intermediate Similarity NPD4380 Phase 2
0.8163 Intermediate Similarity NPD2313 Discontinued
0.8146 Intermediate Similarity NPD2796 Approved
0.8146 Intermediate Similarity NPD2935 Discontinued
0.8137 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8129 Intermediate Similarity NPD6799 Approved
0.8129 Intermediate Similarity NPD1511 Approved
0.8125 Intermediate Similarity NPD2801 Approved
0.8121 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8079 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8075 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8075 Intermediate Similarity NPD3817 Phase 2
0.8069 Intermediate Similarity NPD1203 Approved
0.8063 Intermediate Similarity NPD6801 Discontinued
0.8046 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8026 Intermediate Similarity NPD6100 Approved
0.8026 Intermediate Similarity NPD6099 Approved
0.8025 Intermediate Similarity NPD3882 Suspended
0.8025 Intermediate Similarity NPD1512 Approved
0.8024 Intermediate Similarity NPD3818 Discontinued
0.8012 Intermediate Similarity NPD6166 Phase 2
0.8012 Intermediate Similarity NPD1465 Phase 2
0.8012 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7961 Intermediate Similarity NPD2799 Discontinued
0.7961 Intermediate Similarity NPD4308 Phase 3
0.7945 Intermediate Similarity NPD1470 Approved
0.7935 Intermediate Similarity NPD4628 Phase 3
0.7929 Intermediate Similarity NPD7074 Phase 3
0.7919 Intermediate Similarity NPD411 Approved
0.7905 Intermediate Similarity NPD6832 Phase 2
0.7895 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD5711 Approved
0.7892 Intermediate Similarity NPD5710 Approved
0.7881 Intermediate Similarity NPD447 Suspended
0.7879 Intermediate Similarity NPD5494 Approved
0.7871 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.787 Intermediate Similarity NPD7054 Approved
0.7862 Intermediate Similarity NPD920 Approved
0.7862 Intermediate Similarity NPD9717 Approved
0.7852 Intermediate Similarity NPD4625 Phase 3
0.7824 Intermediate Similarity NPD7472 Approved
0.7811 Intermediate Similarity NPD3751 Discontinued
0.78 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7793 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD5953 Discontinued
0.7778 Intermediate Similarity NPD6797 Phase 2
0.7778 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7756 Intermediate Similarity NPD2800 Approved
0.7742 Intermediate Similarity NPD2344 Approved
0.7742 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD7251 Discontinued
0.7703 Intermediate Similarity NPD2797 Approved
0.7697 Intermediate Similarity NPD4307 Phase 2
0.7688 Intermediate Similarity NPD7808 Phase 3
0.7682 Intermediate Similarity NPD3268 Approved
0.7682 Intermediate Similarity NPD3764 Approved
0.7677 Intermediate Similarity NPD5408 Approved
0.7677 Intermediate Similarity NPD5406 Approved
0.7677 Intermediate Similarity NPD5404 Approved
0.7677 Intermediate Similarity NPD5405 Approved
0.7671 Intermediate Similarity NPD1201 Approved
0.7661 Intermediate Similarity NPD7286 Phase 2
0.7651 Intermediate Similarity NPD2798 Approved
0.7647 Intermediate Similarity NPD1933 Approved
0.7643 Intermediate Similarity NPD1243 Approved
0.7636 Intermediate Similarity NPD4288 Approved
0.7622 Intermediate Similarity NPD37 Approved
0.7619 Intermediate Similarity NPD1608 Approved
0.7614 Intermediate Similarity NPD8150 Discontinued
0.7613 Intermediate Similarity NPD7033 Discontinued
0.761 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD7435 Discontinued
0.759 Intermediate Similarity NPD4966 Approved
0.759 Intermediate Similarity NPD4967 Phase 2
0.759 Intermediate Similarity NPD4965 Approved
0.7578 Intermediate Similarity NPD6273 Approved
0.7568 Intermediate Similarity NPD4749 Approved
0.7566 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD7390 Discontinued
0.7551 Intermediate Similarity NPD1610 Phase 2
0.755 Intermediate Similarity NPD4908 Phase 1
0.7547 Intermediate Similarity NPD2309 Approved
0.7541 Intermediate Similarity NPD6781 Approved
0.7541 Intermediate Similarity NPD6780 Approved
0.7541 Intermediate Similarity NPD6782 Approved
0.7541 Intermediate Similarity NPD6776 Approved
0.7541 Intermediate Similarity NPD6778 Approved
0.7541 Intermediate Similarity NPD6777 Approved
0.7541 Intermediate Similarity NPD6779 Approved
0.7533 Intermediate Similarity NPD1019 Discontinued
0.7532 Intermediate Similarity NPD230 Phase 1
0.7528 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD6844 Discontinued
0.7514 Intermediate Similarity NPD8434 Phase 2
0.75 Intermediate Similarity NPD8151 Discontinued
0.75 Intermediate Similarity NPD6234 Discontinued
0.75 Intermediate Similarity NPD7177 Discontinued
0.75 Intermediate Similarity NPD919 Approved
0.75 Intermediate Similarity NPD9493 Approved
0.7484 Intermediate Similarity NPD7003 Approved
0.7471 Intermediate Similarity NPD7229 Phase 3
0.7471 Intermediate Similarity NPD3787 Discontinued
0.7468 Intermediate Similarity NPD1613 Approved
0.7468 Intermediate Similarity NPD943 Approved
0.7468 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7467 Intermediate Similarity NPD3267 Approved
0.7467 Intermediate Similarity NPD3266 Approved
0.7455 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD422 Phase 1
0.743 Intermediate Similarity NPD4287 Approved
0.7427 Intermediate Similarity NPD3926 Phase 2
0.7419 Intermediate Similarity NPD7696 Phase 3
0.7419 Intermediate Similarity NPD7698 Approved
0.7419 Intermediate Similarity NPD7697 Approved
0.7415 Intermediate Similarity NPD17 Approved
0.7412 Intermediate Similarity NPD7199 Phase 2
0.7405 Intermediate Similarity NPD1471 Phase 3
0.74 Intermediate Similarity NPD1283 Approved
0.74 Intermediate Similarity NPD3225 Approved
0.7399 Intermediate Similarity NPD7228 Approved
0.7386 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.738 Intermediate Similarity NPD7871 Phase 2
0.738 Intermediate Similarity NPD7870 Phase 2
0.7379 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD7874 Approved
0.7368 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7366 Intermediate Similarity NPD6823 Phase 2
0.7353 Intermediate Similarity NPD6746 Phase 2
0.732 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD1247 Approved
0.7308 Intermediate Similarity NPD5124 Phase 1
0.7308 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD1778 Approved
0.7279 Intermediate Similarity NPD1548 Phase 1
0.7278 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD6535 Approved
0.7268 Intermediate Similarity NPD6534 Approved
0.7263 Intermediate Similarity NPD7701 Phase 2
0.7258 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD2979 Phase 3
0.7244 Intermediate Similarity NPD4060 Phase 1
0.724 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.724 Intermediate Similarity NPD7783 Phase 2
0.7229 Intermediate Similarity NPD7458 Discontinued
0.7225 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD8285 Discontinued
0.72 Intermediate Similarity NPD1611 Approved
0.72 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD1281 Approved
0.7196 Intermediate Similarity NPD8320 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data